Skip to main content
Livermore
Livermore
ZHEN

Stanley-Laman Group, Ltd.

SEC CIK
0001601489
Latest filing
Aug 5, 2026

EGRX holding history

Eagle Pharmaceuticals, Inc. in every 13F filed by Stanley-Laman Group, Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EGRX overviewAll 13F holders of EGRXFull Q2 2026 holdings

Shares (Q2 2026)
12,000
Value
$8.04K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of EGRX by Stanley-Laman Group, Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,000$8.04K<0.1%00.0%UnchangedHolders
Q1 202612,000$4.09K<0.1%00.0%UnchangedHolders
Q4 202512,000$8.40K<0.1%00.0%UnchangedHolders
Q3 202512,000$32.4K<0.1%00.0%UnchangedHolders
Q2 202512,000$34.8K<0.1%00.0%UnchangedHolders
Q1 202512,000$11.8K<0.1%00.0%UnchangedHolders
Q4 202412,000$6.00K<0.1%00.0%UnchangedHolders
Q3 202412,000$44.8K<0.1%00.0%UnchangedHolders
Q2 202412,000$67.2K<0.1%00.0%UnchangedHolders
Q1 202412,000$62.9K<0.1%00.0%UnchangedHolders
Q4 202312,000$62.8K<0.1%00.0%UnchangedHolders
Q3 202312,000$189.2K<0.1%00.0%UnchangedHolders
Q2 202312,000$233.3K<0.1%00.0%UnchangedHolders
Q1 202312,000$340.4K0.1%00.0%UnchangedHolders
Q4 202212,000$350.8K0.1%00.0%UnchangedHolders
Q3 202212,000$317.0K0.1%00.0%UnchangedHolders
Q2 202212,000$533.0K0.1%−12,000−50.0%ReducedHolders
Q1 202224,000$1.19M0.2%00.0%UnchangedHolders
Q4 202124,000$1.22M0.1%00.0%UnchangedHolders
Q3 202124,000$1.34M0.2%00.0%UnchangedHolders
Q2 202124,000$1.03M0.1%00.0%UnchangedHolders
Q1 202124,000$1.00M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.